Hedda von der Lippe Gythfeldt

Years Active: 2020-2023
Publications (10 Years): 2

Oslo University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oslo University Hospital

Norway

MD :: Oncology

Publications

Mads Haugland Haugen, Hedda von der Lippe Gythfeldt, Eivind Valen Egeland, Lisa Svartdal Normann, Abhilash D Pandya, Lise-Lotte Vedin, Siri Juell, Ellen Tenstad, Geir Frode Øy, Alexandr Kristian, Elisabetta Marangoni, Therese Sørlie, Knut Steffensen, Gunhild Mari Maelandsmo, Olav Engebraaten
Liver X receptors induce antiproliferative effects in basal-like breast cancer. Molecular oncology (2023)
Hedda von der Lippe Gythfeldt, Tonje Lien, Xavier Tekpli, Laxmi Silwal-Pandit, Elin Borgen, Øystein Garred, Helle Skjerven, Ellen Schlichting, Steinar Lundgren, Erik Wist, Bjørn Naume, Vessela Kristensen, Anne-Lise Børresen-Dale, Ole Christian Lingjaerde, Olav Engebraaten
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer. International journal of cancer 147 (9) (2020)

Hedda von der Lippe Gythfeldt.css-eqlu8i{font-size:small;padding-left:4px;}